Participant flow

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients · Source last updated 2019-08-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Subjects who receive F-18 Fluorothymidine \[FLT\]PET imaging prior to treatment. F-18 Fluorothymidine: FLT PET scan \[0.04 to 0.08 mCi/kg (maximum of 5 mCi +/- 10%)\]

   id

   FG000

   title

   FLT PET

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         7

      type

      Withdrawal by Subject

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      withdraw by subject after scan 1

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         33

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         26

      type

      Recieved FLT PET Scan 1

   3. achievements

      1. group Id

         FG000

         num Subjects

         25

      type

      Received FLT PET Scan #2

   4. achievements

      1. group Id

         FG000

         num Subjects

         25

      type

      COMPLETED

   5. achievements

      1. group Id

         FG000

         num Subjects

         8

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice